A review of the studies on the Model for End-Stage Liver Disease (MELD) found that it is an accurate predictor of survival of patients with a variety of liver diseases, is particularly useful in allocating organs for liver transplants, and can also be used to help determine the course of treatment in certain cases.
A study published in the March 1 issue of the journal Sleep finds that, as opposed to treating insomnia, failure to treat it is much more costly.
Amgen (NASDAQ: AMGN) announced that the U.S. Food and Drug Administration (FDA) has invited the Company to participate at an upcoming meeting of the Oncologic Drugs Advisory Committee (ODAC).
Adults who met with pharmacists or pharmacy students during a community outreach and screening project about metabolic syndrome, returned four months later with lower risk factors for heart disease, researchers reported today at the American Heart Association?s 47th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.
Researchers at Yale have identified multiple pathogenic “alien islands” in the genome of the A. baumannii, bacteria that has been responsible for new and highly drug-resistant infections in combat troops in the Middle East, according to a report in the March 1 issue of Genes and Development.
In clinical studies for the lead indication of multiple sclerosis (MS), Revimmune improves function in most patients and stops progression in over 90 percent of cases refractory to standard therapies.
A comprehensive report released by the Ontario Medical Association (OMA) reveals a reduction in the number of patients in the province without a doctor for the first time in more than five years.
Opening windows can be more effective than using mechanical ventilation at reducing the risk of transmission of airborne diseases such as tuberculosis (TB) – a study funded by the Wellcome Trust and the Sir Halley Stewart Trust.
The U.S. Food and Drug Administration (FDA) has cleared for marketing a modified Colleague Volumetric Infusion Pump which addresses many of the problems that prompted a series of Class I recalls and a product seizure in 2005.
An independent United Nations rights expert denounced a campaign by Filipino milk companies to promote breast-milk substitutes for manipulating UN data to protect their huge profits regardless of the interest of a country where 16,000 children under 5 died in 2003 from improper feeding practices including infant formula.